Skip to main content

ADVERTISEMENT

breast cancer

ASCO Updates Guideline on Early Breast Cancer Treatment
Guideline Updates
11/18/2020
Journal of Clinical Pathways
News
08/06/2020
For women with a family history of breast cancer, magnetic resonance imaging (MRI) every 18 months between the ages of 35 and 60 is a cost-effective screening strategy, according to results from a study published in...
For women with a family history of breast cancer, magnetic resonance imaging (MRI) every 18 months between the ages of 35 and 60 is a cost-effective screening strategy, according to results from a study published in...
For...
08/06/2020
Journal of Clinical Pathways
Enhancing the Electronic Health Record to Improve the Quality of Breast Cancer Care in Eastern North Carolina
From the Field
05/19/2020
Helen M Johnson, MD
Lauren E Geisel, MD
 Andrew Weil, MD
Mahvish Muzaffar, MD
Nasreen A Vohra, MD
Phyllis DeAntonio, RN
Jan H Wong, MD
Abstract: Eastern North Carolina (ENC) is home to a rural population that suffers from disparities in breast cancer outcomes. It has been demonstrated that evidence-based clinical pathways can improve quality of...
Abstract: Eastern North Carolina (ENC) is home to a rural population that suffers from disparities in breast cancer outcomes. It has been demonstrated that evidence-based clinical pathways can improve quality of...
...
05/19/2020
Journal of Clinical Pathways
From the Field
02/15/2018
Bruce A Feinberg, DO
Chadi Nabhan, MD, MBA, FACP
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...
Abstract: Clinical...
02/15/2018
Journal of Clinical Pathways
News
08/22/2017
JCP Editors
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less...
08/22/2017
Journal of Clinical Pathways
News
08/22/2017
JCP Editors
A recent comparative effectiveness study examined long-term survival outcomes for patients with multiple stages of breast cancer after undergoing either mastectomy or breast-conserving surgery, published in the...
A recent comparative effectiveness study examined long-term survival outcomes for patients with multiple stages of breast cancer after undergoing either mastectomy or breast-conserving surgery, published in the...
A...
08/22/2017
Journal of Clinical Pathways
Research in Review
08/17/2017
JCP Editors
Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...
Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...
...
08/17/2017
Journal of Clinical Pathways
Research in Review
08/14/2017
JCP Editors
An immuno-agent improves progression-free survival (PFS) and lowers the risk of death for patients with human epidermal growth factor 2 (HER2)-negative metastatic breast cancer and a germline BRCA mutation, according...
An immuno-agent improves progression-free survival (PFS) and lowers the risk of death for patients with human epidermal growth factor 2 (HER2)-negative metastatic breast cancer and a germline BRCA mutation, according...
An...
08/14/2017
Journal of Clinical Pathways
Research in Review
08/09/2017
JCP Editors
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...
More...
08/09/2017
Journal of Clinical Pathways
Research in Review
07/31/2017
JCP Editors
A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based human epidermal growth factor receptor 2 (HER2)...
A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based human epidermal growth factor receptor 2 (HER2)...
A low...
07/31/2017
Journal of Clinical Pathways